Predictive biomarkers for disease sensitivity in lymphoma - the holy grail for HDAC inhibitors?

ABSTRACT:

SUBMITTER: Eyre TA 

PROVIDER: S-EPMC6324661 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature